Latest Observability News

LTR Pharma has increased its ownership in LevOmega to approximately 43% through a strategic A$1 million investment, reinforcing its commitment to sustainable, pharmaceutical-grade omega-3 development.

Great Boulder Resources reports significant high-grade gold intersections at its Side Well South prospect, advancing rapidly towards an initial Mineral Resource Estimate. The latest drilling highlights wide, shallow mineralisation that could boost the project’s overall gold inventory.

Felix Gold Limited has been found in breach of ASX continuous disclosure rules after delaying the announcement of a U.S. federal site visit to its Alaska antimony project, prompting an internal review of its disclosure policies.

Eclipse Metals has commenced mobilisation for its 2025 diamond drilling program at the Grønnedal Rare Earths Carbonatite Complex in Greenland, aiming to expand a significant rare earth mineral resource rich in critical magnet metals.

DFA Australia Limited has announced the Distribution Reinvestment Plan (DRP) issue prices for its Dimensional Australian Core Equity Trust and Australian Value Trust following the September 2025 distribution.

Infini Resources has identified visible uraninite at its Reitenbach Lake project and confirmed widespread radiometric anomalies at Reynolds Lake, advancing its uranium exploration in Saskatchewan. Assay results expected in Q4 2025 will guide a potential drilling campaign in 2026.

Aurora Labs has secured a $450,000 Phase 2 contract from the Australian Department of Defence to prototype a high-thrust, fuel-efficient propulsion system for unmanned aerial systems, building on its innovative 3D metal printing technology.

Pacific Smiles Group announces the resignation of CEO Gary Carroll and the appointment of Michelle Dries as his successor, signaling a new chapter for the dental services provider.

Linius Technologies has addressed a late filing of a director's interest notice, attributing the delay to an administrative oversight involving a new class of securities. The company has updated its processes and will re-brief directors to ensure future compliance.

American Uranium Limited confirms the start of phase one resource drilling at its Lo Herma uranium project in the U.S. this October, aiming to grow its mineral resource and support a 2026 scoping study update.

Chimeric Therapeutics reports encouraging Phase 1B data from its ADVENT-AML trial, showing safety and multiple complete responses in high-risk AML patients treated with CORE-NK combined with standard therapies.

Brazilian Critical Minerals Ltd has raised A$6 million through a well-supported placement to fast-track its flagship Ema Rare Earths Project in Brazil, aiming to move closer to commercial production.